• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国轻、中、重度肺动脉高压女性的妊娠情况和结局。

Pregnancy conditions and outcomes of Chinese women with mild, moderate and severe pulmonary arterial hypertension.

机构信息

Department of Cardiology, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, PR China.

Department of Gynecology and Obstetrics, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, PR China.

出版信息

Hypertens Res. 2024 Sep;47(9):2561-2573. doi: 10.1038/s41440-024-01795-4. Epub 2024 Jul 16.

DOI:10.1038/s41440-024-01795-4
PMID:39014115
Abstract

Pregnancy is normally contraindicated in pulmonary arterial hypertension (PAH). Thanks to medical advances, the prognosis for pregnancy in patients with PAH has improved. The aim of our study was to investigate pregnancy conditions and outcomes in patients with mild, moderate and severe PAH. We searched PubMed, Embase, CNKI, Wanfang and Weipu databases for studies published before May 2024. Data from 29 included studies from 1898 references were pooled and analyzed. We calculated the rates for each group as well as the risk ratio (RR) and 95% confidence interval (CI) between pairwise. There was no statistical difference in maternal and neonatal survival between the mild and moderate groups. Maternal survival in the mild, moderate and severe groups was 100.0%, 99.7% and 88.8%, respectively, and neonatal survival was 100.0%, 99.7% and 96.0%, respectively. The incidence of NYHA class III-IV, pregnancy loss, intensive care unit (ICU) admission, fetal growth restriction, and neonatal asphyxia was lowest in patients with mild PAH and highest in patients with severe PAH (P < 0.001). The incidence of vaginal deliveries and term pregnancies was highest in the mild group and lowest in the severe group (P < 0.001). In conclusion, pregnant women with mild PAH can safely deliver a newborn. Given similar survival rates but greater economic and medical burdens, caution is advised in the moderate group. Pregnancy in the severe group is considered contraindicated.

摘要

妊娠在肺动脉高压(PAH)中通常是禁忌的。由于医学的进步,PAH 患者的妊娠预后已经得到改善。我们的研究目的是调查轻度、中度和重度 PAH 患者的妊娠情况和结局。我们检索了 PubMed、Embase、CNKI、万方和维普数据库,以获取截至 2024 年 5 月之前发表的研究。从 1898 篇参考文献中纳入了 29 项研究的数据,并进行了汇总和分析。我们计算了每组的发生率,并计算了两两之间的风险比(RR)和 95%置信区间(CI)。轻度和中度组的母婴存活率没有统计学差异。轻度、中度和重度组的产妇存活率分别为 100.0%、99.7%和 88.8%,新生儿存活率分别为 100.0%、99.7%和 96.0%。NYHA 分级 III-IV、妊娠丢失、入住重症监护病房(ICU)、胎儿生长受限和新生儿窒息的发生率在轻度 PAH 患者中最低,在重度 PAH 患者中最高(P<0.001)。轻度组阴道分娩和足月妊娠的发生率最高,重度组最低(P<0.001)。总之,轻度 PAH 孕妇可以安全分娩新生儿。鉴于相似的存活率但更大的经济和医疗负担,中度组需要谨慎。重度组妊娠被认为是禁忌的。

相似文献

1
Pregnancy conditions and outcomes of Chinese women with mild, moderate and severe pulmonary arterial hypertension.中国轻、中、重度肺动脉高压女性的妊娠情况和结局。
Hypertens Res. 2024 Sep;47(9):2561-2573. doi: 10.1038/s41440-024-01795-4. Epub 2024 Jul 16.
2
Pregnancy feasibility in women with mild pulmonary arterial hypertension: a systematic review and meta-analysis.患有轻度肺动脉高压的女性妊娠可行性:系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2023 Jun 8;23(1):427. doi: 10.1186/s12884-023-05752-w.
3
Pregnancy outcomes in patients with pulmonary arterial hypertension: A retrospective study.肺动脉高压患者的妊娠结局:一项回顾性研究。
Medicine (Baltimore). 2020 Jun 5;99(23):e20285. doi: 10.1097/MD.0000000000020285.
4
[Pregnancy outcomes of 103 women with pulmonary arterial hypertension].103例肺动脉高压女性的妊娠结局
Zhonghua Fu Chan Ke Za Zhi. 2013 Sep;48(9):659-62.
5
Neonatal outcomes in pregnant women with pulmonary arterial hypertension associated with heart disease.患有心脏病的肺动脉高压孕妇的新生儿结局。
Pediatr Neonatol. 2023 Jul;64(4):450-454. doi: 10.1016/j.pedneo.2022.11.008. Epub 2023 Jan 25.
6
[Long-term outcome and prognostic factors in pregnant women with pulmonary arterial hypertension associated with congenital heart disease].[先天性心脏病相关肺动脉高压孕妇的长期结局及预后因素]
Zhonghua Nei Ke Za Zhi. 2017 Nov 1;56(11):827-832. doi: 10.3760/cma.j.issn.0578-1426.2017.11.010.
7
Evaluation of maternal and fetal outcomes in pregnancy complicated with pulmonary arterial hypertension.妊娠合并肺动脉高压的母婴结局评估
Ann Palliat Med. 2021 Feb;10(2):1404-1410. doi: 10.21037/apm-20-551. Epub 2020 Oct 29.
8
Clinical outcomes of pulmonary hypertension in pregnancy among women with congenital heart disease in China.中国先天性心脏病孕妇妊娠相关肺动脉高压的临床结局。
J Matern Fetal Neonatal Med. 2023 Dec;36(1):2183349. doi: 10.1080/14767058.2023.2183349.
9
[Obstetric outcome in pregnancy complained with pulmonary hypertension].[合并肺动脉高压妊娠的产科结局]
Zhonghua Yi Xue Za Zhi. 2017 Dec 19;97(47):3711-3715. doi: 10.3760/cma.j.issn.0376-2491.2017.47.006.
10
Effects of maternal pulmonary arterial hypertension on fetal hemodynamics and maternal-fetal outcome in late pregnancy.孕晚期母体肺动脉高压对胎儿血流动力学及母胎结局的影响。
Echocardiography. 2023 Dec;40(12):1339-1349. doi: 10.1111/echo.15708. Epub 2023 Nov 3.

引用本文的文献

1
IDO-Dependent Tryptophan Metabolites and Endocan as Effective Diagnostic Biomarkers for Pregnancy with Pulmonary Hypertension.吲哚胺2,3-双加氧酶依赖性色氨酸代谢产物和内脂素作为妊娠合并肺动脉高压的有效诊断生物标志物
Int J Womens Health. 2025 Jul 19;17:2205-2216. doi: 10.2147/IJWH.S527345. eCollection 2025.

本文引用的文献

1
Maternal and Neonatal Outcomes in Pregnancy Complicated with Pulmonary Hypertension.妊娠合并肺动脉高压的母婴结局
Rev Cardiovasc Med. 2022 May 12;23(5):172. doi: 10.31083/j.rcm2305172. eCollection 2022 May.
2
Pregnancy feasibility in women with mild pulmonary arterial hypertension: a systematic review and meta-analysis.患有轻度肺动脉高压的女性妊娠可行性:系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2023 Jun 8;23(1):427. doi: 10.1186/s12884-023-05752-w.
3
Maternal Outcomes Among Pregnant Women With Congenital Heart Disease-Associated Pulmonary Hypertension.
先天性心脏病相关肺动脉高压孕妇的母婴结局。
Circulation. 2023 Feb 14;147(7):549-561. doi: 10.1161/CIRCULATIONAHA.122.057987. Epub 2023 Feb 13.
4
Sex differences and altered mitophagy in experimental pulmonary hypertension.实验性肺动脉高压中的性别差异和改变的线粒体自噬。
Am J Physiol Lung Cell Mol Physiol. 2022 May 1;322(5):L761-L769. doi: 10.1152/ajplung.00019.2020. Epub 2022 Feb 9.
5
Sex and gender in pulmonary arterial hypertension.肺动脉高压中的性别和性别差异。
Eur Respir Rev. 2021 Nov 8;30(162). doi: 10.1183/16000617.0330-2020. Print 2021 Dec 31.
6
Pulmonary arterial hypertension in pregnancy-a systematic review of outcomes in the modern era.妊娠期肺动脉高压——现代时代结局的系统评价
Pulm Circ. 2021 May 14;11(2):20458940211013671. doi: 10.1177/20458940211013671. eCollection 2021 Apr-Jun.
7
Peripartum considerations for women with cardiac disease.围产期心脏病患者的注意事项。
Curr Opin Anaesthesiol. 2021 Jun 1;34(3):218-225. doi: 10.1097/ACO.0000000000000992.
8
Pulmonary Hypertension in Pregnancy.妊娠性肺动脉高压。
Clin Chest Med. 2021 Mar;42(1):91-99. doi: 10.1016/j.ccm.2020.10.006. Epub 2021 Jan 9.
9
Evaluation of maternal and fetal outcomes in pregnancy complicated with pulmonary arterial hypertension.妊娠合并肺动脉高压的母婴结局评估
Ann Palliat Med. 2021 Feb;10(2):1404-1410. doi: 10.21037/apm-20-551. Epub 2020 Oct 29.
10
Eisenmenger Syndrome in Pregnancy: A Management Conundrum.妊娠合并艾森曼格综合征:管理难题
J Cardiothorac Vasc Anesth. 2020 Oct;34(10):2813-2822. doi: 10.1053/j.jvca.2020.02.053. Epub 2020 Mar 6.